Oncology News | pharmaphorum

News

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi

Regulatory T-cell scientist trio wins Nobel Prize

The Nobel Prize in Physiology or Medicine goes to three scientists for their work on regulatory T-cells, spawning hundreds of trials of new therapies.

News

Dr Ken Macnamara, Trogenix's chief executive

UK's Trogenix raises £70m for cancer immunotherapy platform

Edinburgh-based Trogenix has raised £70m to fund clinical trials of its triple-acting immunotherapies for brain and colorectal cancers.

News

Delayed TNBC readout for Datroway delivers survival benefit

AstraZeneca and Daiichi Sankyo's Datroway comes good in the delayed TROPION-Breast02 trial as a frontline triple-negative breast cancer treatment.

News

Jazz, Roche combo cleared by FDA for lung cancer

Can FDA approval of Jazz Pharma's Zepzelca in a combination regimen for extensive-stage small cell lung cancer return sales of the drug to growth?

News

Bar graph of gold coins increasing from left to right, with plants growing out the top

Crystalys emerges with $205m, and other biofinancings

Recent biotech financings include big rounds for Crystalys and Star Therapeutics, with Sparrow, Avenzo, and Aerska also raising new funds.

News

Umoja's in vivo cell therapy fast-tracked by FDA

A pioneer of in vivo cell therapy, Umoja has cleared another regulatory milestone by getting fast-track status for its lead blood cancer programme.

Regulatory T-cell scientist trio wins Nobel Prize

UK's Trogenix raises £70m for cancer immunotherapy platform

Delayed TNBC readout for Datroway delivers survival benefit

Jazz, Roche combo cleared by FDA for lung cancer

Crystalys emerges with $205m, and other biofinancings

Umoja's in vivo cell therapy fast-tracked by FDA

Praxis soars on rare childhood epilepsy trial data

How to meet your physicians where they are online

News

Editor's Picks